Market cap
$23 Mln
Revenue (TTM)
$1 Mln
P/E Ratio
--
P/B Ratio
12
Div. Yield
0 %
| Research Frontiers (REFR) | Warner Music Group Corp. Class A (WMG) | Madison Square Garden Sports Corp. Class A (New) (MSGS) | LiveOne (LVO) | Pharmhouse Corp (PHSE) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
23 | 14,658 | 9,503 | 42 | 46 |
Revenue ($ Mln) |
1 | 7,304 | 1,154 | 77 | 7 |
Net Profit ($ Mln) |
-2.25 | 672.00 | 7.76 | -19.97 | -12.93 |
Net Margin (%) |
-343.85 | 9.20 | 0.67 | -25.83 | -195.91 |
RoE (%) |
-218.76 | 86.28 | -2.85 | -- | -26.19 |
Price to Earnings |
-- | 22.42 | 1,233.25 | -- | -- |
Price-To-Book |
12.00 | 17.16 | 1.57 | 27.53 | 0.90 |
Income Statement ($ Mln)
| Research Frontiers (REFR) | Warner Music Group Corp. Class A (WMG) | Madison Square Garden Sports Corp. Class A (New) (MSGS) | LiveOne (LVO) | Pharmhouse Corp (PHSE) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
0.65 | 7,304.00 | 1,153.82 | 77.29 | 6.60 |
|
Cost of Revenue
|
0.66 | 3,961.00 | 833.70 | 64.10 | 1.54 |
|
Gross Profit
|
0.93 | 3,075.00 | 280.88 | 27.22 | 2.35 |
|
Operating Expenses
|
2.84 | 2,298.00 | 291.25 | 28.31 | 17.25 |
|
Operating Profit (EBIT)
|
-2.28 | 1,045.00 | 28.87 | -15.12 | -12.19 |
|
Other Income
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
-2.25 | 873.00 | 17.98 | -20.45 | -12.61 |
|
Provision for Tax
|
0.00 | 208.00 | 10.22 | 0.02 | 0.00 |
|
Profit after Tax (Net Income)
|
-2.25 | 672.00 | 7.76 | -19.97 | -12.93 |
|
Minority Interest
|
0.00 | 7.00 | 0.00 | 0.52 | 0.00 |
|
Consolidated Profit
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Liabilities ($ Mln)
| Research Frontiers (REFR) | Warner Music Group Corp. Class A (WMG) | Madison Square Garden Sports Corp. Class A (New) (MSGS) | LiveOne (LVO) | Pharmhouse Corp (PHSE) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
1.12 | 854.00 | -263.30 | -13.68 | 46.40 |
|
Minority Interest
|
0.00 | 7.00 | 0.00 | 0.52 | 0.00 |
|
Non-Current Liabilities
|
0.94 | 5,198.00 | 1,158.51 | 19.67 | 0.17 |
|
Current Liabilities
|
0.41 | 4,443.00 | 642.44 | 34.10 | 7.25 |
|
Total Liabilities
|
2.25 | 9,829.00 | 1,580.77 | 40.52 | 60.35 |
Assets ($ Mln)
| Research Frontiers (REFR) | Warner Music Group Corp. Class A (WMG) | Madison Square Garden Sports Corp. Class A (New) (MSGS) | LiveOne (LVO) | Pharmhouse Corp (PHSE) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
1.02 | 7,467.00 | 1,214.36 | 26.96 | 50.01 |
|
Current Assets
|
1.46 | 3,260.00 | 323.29 | 21.77 | 3.81 |
|
Total Assets
|
2.25 | 9,829.00 | 1,580.77 | 40.52 | 60.35 |
|
Total Debt*
|
1.09 | 4,919.00 | 1,143.81 | 14.35 | 4.71 |
|
Net Current Assets
|
1.04 | -1,183.00 | -319.15 | -13.18 | 0.00 |
Cashflow ($ Mln)
| Research Frontiers (REFR) | Warner Music Group Corp. Class A (WMG) | Madison Square Garden Sports Corp. Class A (New) (MSGS) | LiveOne (LVO) | Pharmhouse Corp (PHSE) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-1.33 | 678.00 | 91.61 | 6.37 | -2.49 |
|
Cash Flow from Investing Activities
|
0.00 | -340.00 | -6.92 | -3.12 | 0.01 |
|
Cash from Financing Activities
|
0.00 | -497.00 | -26.41 | -6.24 | 1.46 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Research Frontiers (REFR) | Warner Music Group Corp. Class A (WMG) | Madison Square Garden Sports Corp. Class A (New) (MSGS) | LiveOne (LVO) | Pharmhouse Corp (PHSE) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-68.18 | 7.14 | -2.58 | 407.56 | -32.70 |
|
ROE (%)
|
-218.76 | 86.28 | 8.19 | 173.58 | -26.19 |
|
ROA (%)
|
-70.97 | 4.63 | 0.36 | -23.97 | -44.52 |
|
EBIT Margin (%)
|
-345.32 | 14.09 | 3.39 | -16.53 | -55.58 |
|
Net Margin (%)
|
-343.85 | 9.20 | 0.67 | -25.83 | -195.91 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | -- |
Growth Ratios
| Research Frontiers (REFR) | Warner Music Group Corp. Class A (WMG) | Madison Square Garden Sports Corp. Class A (New) (MSGS) | LiveOne (LVO) | Pharmhouse Corp (PHSE) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-46.47 | 12.91 | 11.03 | -23.12 | -- |
|
EBIT Growth (%)
|
-28.64 | 73.23 | 791.96 | -30.73 | -- |
|
Net Profit Growth (%)
|
-28.09 | 126.26 | 134.58 | -4.90 | -558.18 |
|
EPS Growth (%)
|
-26.11 | 125.27 | 133.77 | -48.89 | -232.55 |
|
Book Value Growth (%)
|
-39.72 | 44.12 | 7.01 | 52.17 | 843.86 |
Valuation Ratios
| Research Frontiers (REFR) | Warner Music Group Corp. Class A (WMG) | Madison Square Garden Sports Corp. Class A (New) (MSGS) | LiveOne (LVO) | Pharmhouse Corp (PHSE) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-21.55 | 48.43 | -224.47 | -3.59 | -19.49 |
|
Price / Book Value
|
47.21 | 27.32 | -17.90 | -3.78 | 3.51 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-23.98 | 19.53 | 798.66 | -5.34 | -20.71 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Research Frontiers (REFR) | Warner Music Group Corp. Class A (WMG) | Madison Square Garden Sports Corp. Class A (New) (MSGS) | LiveOne (LVO) | Pharmhouse Corp (PHSE) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 5.52 | -0.92 | -0.81 | 0.00 |
|
Short term debt to equity ratio
|
0.14 | 0.05 | -0.22 | -0.23 | 0.10 |
|
Current Ratio
|
3.54 | 0.73 | 0.50 | 0.64 | 0.53 |
|
Quick Ratio
|
3.54 | 0.72 | 0.50 | 0.62 | 0.51 |
|
Interest Coverage
|
-- | 5.99 | 1.85 | -3.91 | -60.18 |
Operating Efficiency Ratios
| Research Frontiers (REFR) | Warner Music Group Corp. Class A (WMG) | Madison Square Garden Sports Corp. Class A (New) (MSGS) | LiveOne (LVO) | Pharmhouse Corp (PHSE) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
31.79 | 31.19 | 7.65 | 11.43 | 3.70 |
|
Asset Turnover
|
0.21 | 0.50 | 0.53 | 0.93 | 0.23 |
|
Receivable days
|
173.77 | 70.66 | 21.72 | 34.33 | 19.75 |
|
Inventory Days
|
-- | 8.10 | -- | 7.09 | 34.86 |
|
Payable days
|
213.75 | 27.45 | 7.41 | 63.72 | 253.06 |
|
Cash Conversion Cycle
|
-- | 51.30 | -- | -22.30 | -198.45 |